text:
Deven Hurst will serve as Zipper's exclusive manufacturer's representative for the Southeast region of the U.S.
Zipper Mower of Augusta, KS has appointed Deven Hurst as Zipper's exclusive manufacturer's representative of the Southeast region of the U.S. Hurst will be representing the entire Zipper product line in the states of Florida, Georgia, North Carolina, South Carolina and Alabama.
Hurst brings strong industry credentials from Husqvarna, and distributors for Stihl and Snapper. "My experience in dealer management, merchandising and marquee account development gives me a great base of experience from which I can support and grow the Zipper dealer base in this region." said Hurst. Tom Glaze, vice president and general manager of Zipper Mowers said "We look forward to the high level of growth and support that we know Deven can bring to the Zipper team."
Start small if you are thinking about adding design/build services to your portfolio.
For the second time, The Riverside Company has acquired the Texas franchising company.
How Noon Turf Care leverages technology to run its business.
Total Lawn Care tailors a customer-friendly approach to lawn care.
FMC will develop and market two turf and ornamental products for Arysta LifeScience.


text:
This site features some really superb illustrations, animated background objects and a mouse-powered parallax effect. It is a beautiful design from top to bottom and the developers really went all out on the eye candy.Posted in Web Design → Software
An excellent design featuring a bright yellow background and realistic sliders. I love how big everything is, especially the download and preview buttons near the bottom.Posted in Web Design → Design
This is a neat portfolio site where you flip through a book to see the past work of the agency. The wooden background is a nice implementation of texture, the UI is great and the site is just fun to play with!Posted in Web Design → Portfolio

subset: commoncrawl


text:
Sorority Row is a 2009 American slasher film, and a re-imagining of the 1983 slasher film The House on Sorority Row. It was directed by Stewart Hendler, written by Josh Stolberg and Pete Goldfinger, and stars Briana Evigan, Leah Pipes, Rumer Willis, Jamie Chung, Margo Harshman, Audrina Patridge, Caroline D'Amore and Carrie Fisher.
List of links to Sorority Row fansites:
Register to update information, save favorites, post photos, news stories and comments. A LucyMe.com login allows you to edit our four websites.


text:
- Mobile site
- E-Newsletters
- News feed
- Find us on Twitter
Follow Watford Observer on Twitter
- Find us on Facebook
Watford Observer
Like us on Facebook
Maintenance work to be carried out at Croxley Great Barn (From Watford Observer)
Get involved: send your pictures, video, news and views by texting WO to 80360, or upload here
Maintenance work to be carried out at Croxley Great Barn
3:50pm Friday 27th June 2014 in News By Frazer Ansell
The historic Croxley Great Barn in All Saints Road, Croxley Green, will be treated to some tender, loving, care next week when up to 40 conservation experts and volunteer heritage enthusiasts descend upon it to carry out much-needed maintenance and repairs.
The working party has been organised by the Society for the Protection of Ancient Buildings (SPAB) who will spend a week working on the barn which has survived since medieval times.
This year's work will be part-funded by a Sharing Heritage grant of £4,100 from the Heritage Lottery Fund.
Each year SPAB, Britain's oldest conservation body founded by William Morris in 1877, decamps for a week from its London HQ to put its advice and expertise into practice at a building in need.
This is the second year the society has held its working party at Croxley Great Barn and this time around they will be opening the site up to the local community.
Visitors will be welcome to watch conservation in action at the barn from 10am until 5pm on Wednesday (July 2).
Some of the best craftspeople in the country will be on hand to teach visitors brick-making, flint knapping, stone masonry and wood work skills. There will also be historic tours of the barn at 10am, noon, 2pm and 4pm. Access to the barn by car is via Lavrock Lane.
Croxley Great Barn is a hidden medieval monastic barn built at the end of the 14th century.
Remarkably unchanged in 700 years, it is one of the largest of its type in Hertfordshire - standing approximately 31m in length and 12m wide.
The barn's soaring space and arching beams give it the appearance of a wooden cathedral. This is appropriate, given that it was probably built for Abbott John Moote of St Albans Abbey.
Comments are closed on this article.


text:
Homes for Sale in Smithfield, VA
Featured: Real Estate in Smithfield, Virginia
We're sorry.
No results were returned for Smithfield, VA Homes for Sale but we do have some suggestions:
Search for all real estate in same location:
All Real Estate in Smithfield, VA (196 listings)
Same search, but in nearby areas:
Home Buying Resources
Ask a Question
Recently asked questions in Virginia. More Q&A
I am a first time home buyer. What do i need to know 14 answers
Contact a Local Agent
Connect with Buyer Agents in your area to get your questions answered.


text:
I'm running a Google Adwords campaign, and I would like to know where my users came from. I have a form allowing them to leave an application, and I need to attach the information about the keywords to the application user leaves.
Now I do two things:
1. Attach information from $_SERVER['HTTP_REFERER'] to the form. And I have my applications coming in the following format:
Name: name
Skype: skype
Referer: http://googleads.g.doubleclick.net/pagead/ads?client=ca-pub-6279739740619787&output=html&h=250&slotname=4467623023&adk=125461787&w=300&lmt=1384570112&flash=0&url=http%3A%2F%2Fwww.softmozer.com%2Fdownloading-android%2Fviber-mobile&dt=1384598912575&bdt=1666&shv=r20131112&cbv=r20130906&saldr=sb&prev_slotnames=6478798083&correlator=1384598912354&frm=20&ga_vid=322040364.1384598912&ga_sid=1384598912&ga_hid=825269062&ga_fc=0&u_tz=480&u_his=2&u_java=1&u_h=640&u_w=360&u_ah=640&u_aw=360&u_cd=32&u_nplug=0&u_nmime=0&dff=arial&dfs=12&adx=0&ady=397&biw=980&bih=1543&oid=3&ref=http%3A%2F%2Fwww.softmozer.com%2Fdownload-android%2Fviber-mobile.html&vis=1&fu=0&ifi=2&dtd=24&xpc=8EEeOm8Hca&p=http%3A//www.softmozer.com
But this way is bad for two reasons:
- HTTP_REFERER doesn't work in all browsers.
- Don't really know if getting keywords is possible in cases of all URLs like in the example.
2. Set up goals in Google Analytics. It allows me to know how many goals were accomplished from a specific keyword. But it doesn't allow to determine from which keyword I received that specific application.
What way would you suggest to determine keywords from which the user came to the page?


text:
- #GroveWatch: The countdown to campus' newest housing option – Aug. 19
- #CardmailProbs: An end in sight?
- #GroveWatch: The countdown to campus' newest housing option – Aug. 11
- Emails fail to send after attempt to upgrade software – part four
- Brief: LMPD charges suspect in HSC crimes
- Brief: ULPD detain suspect in attempted break-in
- Sodexo plans new restaurant, extended hours
- PHOTOS: Iconic silos being torn down
- Students concerned after HSC robberies
- Brief: LMPD says HSC armed robberies connected
Feature: Opening Day Magic
By Lilly Trunnell
On a sunny Friday evening in Charleston, South Carolina, the Louisville Cardinals opened their 2014 baseball season against West Virginia at the Hollywood Suites Tournament hosted by The Citadel. The first game went into ten regulation innings and ended with a Cardinals win in the most exiting way.
With one out and no one on base, Senior LF Jeff Gardner whacked one down the right field line and out of the park against West Virginia RHP Corey Walter, giving the Cardinals their first walk-off on a home run since 2010. The final score came in at 7-6, with the Cardinals coming back from a once 5-1 deficit.
The magnificence of the win did not come without a trade off. Junior SS Sutton Whiting left the game in the ninth inning after being hit in the face by the pitch. He was taken to a local hospital and shown to have a fractured nose. As of the next day, he had returned to the team but not to the lineup. There is not yet a timeline for his return.
The loss of Whiting in the lineup is the loss of one of four Cardinal captains. However, Gardner quickly made up for the loss. As another captain, he proved to the team, the fans, and the critics that the loss of one does not mean the downfall of many. Though Louisville struggled through the first several innings, the comeback is an example of things we may be looking at later in the season.
The starter for the game was junior LHP Joe Filomeno. Filomeno lasted four innings, allowing seven hits and five runs, four of which were earned. In the fifth, freshman RHP Jake Sparger replaced the struggling Filomeno on the mound. He came in with a 5-1 deficit, and managed to stem the flow to three hits and one run over the next five innings. Junior standout RHP Nick Burdi came in to pitch a hitless, scoreless tenth, giving way to Gardner's walk-off home run in the bottom of the inning. Burdi is the pitcher of record with a win.
The Cardinals committed three errors within their first ten innings of play on the season. The three errors resulted in one unearned run. Though the Cardinals mark this one in the books as a win, errors should be watched carefully over the next few weeks to determine if they become game-changing elements.
In the line-up, seniors Gardner and RF Cole Sturgeon both proved to be bright spots, with two hits each in five at bats and each scoring two runs. Gardner had two RBI's in addition, including his game-winning solo homer. The Cardinals left a total of five runners on base.
With a mix of young and old players and many new faces, Louisville will be looking for leadership from older, experienced players like Gardner and Sturgeon to lead the Cardinals to victory this season.
Now that their first game is out of the way, the Cardinals play twice more in South Carolina before returning to Jim Patterson Stadium for their first game in Louisville against EKU on Wednesday. First pitch is scheduled for 3:00 P.M.


text:
Popular now on WCYB.com
America's best airlines of 2014
POSTED: 1:03 PM May 15 2013 UPDATED: 6:00 AM May 15 2014
Text Size:
These airlines are tops when it comes to customer satisfaction.
The views expressed are not those of this site, this station or its affiliated companies. By posting your comments you agree to accept our terms of use.
Around The Watercooler
- Cops: Woman swallows stolen ring to 'hide it'
- Russian bank offers cats with mortgages
- 99 cans of beer in a pack
- PD: Mom hung up on missing child call to strip
- Feral cat forces elementary school to close
- The people who create their own 'countries'
- Cops: Meth suspects threw toilet at imagined attackers
- Police: Woman tried to burn down ex's house with bacon
- Giraffe tries to ride motorcycle (and fails)


text:
Gallery Hotlinks
Top Images
Worst Images
Top Members
Image Info
Total Members: 29609
Total Images: 29406
Total Rated: 25154
Total Votes: 746265
Total Downloads: 2470200
Total Comments: 150363
How to Comment?
How To Upload?
dey does probably real crack up on this in malaysia, where jeeva from
what dat suppose 2 mean?
sign language............
i tink d image jedd jeeva
the deaf is not funnii


text:
Vacation Rentals in Elizabethtown, Pennsylvania
Search vacation deals on homes, villas, cabins, cottages, apartments and condos in destinations all over the world. Click the "rental results" tab to browse Elizabethtown, Pennsylvania vacation rentals and inquire about your favorites. If you cant find what youre looking for, consider nearby destinations, or come back for a visit - vacation home rentals in Elizabethtown are added and updated every week!
Compared to hotels, Elizabethtown vacation rentals are much more family-friendly and flexible, offering a lot more space, a lot more savings, and a lot more amenities - like private pools, gourmet kitchens, and pet-friendly accommodations! Tip: Save money by taking advantage of cheap weekly rates.
Elizabethtown, Pennsylvania Vacation Rentals and Tourism
more destinations
Check out more areas which feature homes, villas, cabins, cottages, or condos.
Elizabethtown things to do
Bube's Brewery
This review is for the Catacombs, not the Brewery. For the second year in a row, we had dinner here for our anniversary. While on the expensive side, the...read more
Shank's Mare Outfitters
I rent kayaks from here. The current price for a single-person kayak is $26 for 2 hours (which includes kayak, paddle & life-jacket), then $8 for every hour...read more
Great family amusement park. Look online for coupon codes before purchasing tickets. I saved $14 on each. The ticket counter scans the barcode from your...read more
Hershey's Chocolate World
Hershey's Chocolate World is a glorified souvenir shop, and unless you're in the market for cool candy-related gear, it's not really worth the stop. The...read more
National Watch and Clock Museum
Great collection of clocks, from tall to cuckoo to novelties. Lots of interesting history and good displays. The art section was weird, and I wish more...read more
The Hershey Story
Great way to end our last day at Hershey. The museum is interactive with a lot of exhitbits on Milton Hershey and the Hershey chocolate company. It was...read more
Movietown Cinemas
Nothing special, but it's a couple blocks from my house. I wouldn't go out of my way to go to this theater. Prices are better than other theaters.read more
Cullari Vineyards & Winerys
The wine is great and the staff is amazing! The cheese, wine, crackers, and dips are all included in the tasting. The staff crack me up, very light...read more
Hershey Bears
B-E-A-R-S, Bears, Bears, Bears, Woooo! Family oriented place for wholesome fun! Hershey Bears are currently the AHL affiliate team of Washington Capitals,...read more
E-Dance Center
I was 30 and had never taken a dance class in my life and had heard that e-dance center offers multiple classes for adults, including hip-hop which sparked...read more
Elizabethtown Fitness Club
This is my home gym, and I love it here. The people are super nice, and super involved. They make me feel really welcome, and I look forward to going to...read more
Nissley Vineyards
Beautiful setting, some nice wines. 6 tastings for free (many different prices mentioned on yelp!). Very small store no snacks available. Folks nice. There...read more
Conewago Recreation Trail
I am astonished how anyone can give this less than 5 stars. Very smooth, very flat, very well maintained, and lots of shade for the hot summer days. Get...read more
The Vineyard At Grandview
Very nice winery. Great views and beautiful deck. The inside of the winery is spacious and I did not feel cramped. There were two bridal showers going on...read more
Allen Theatre & Coffee House
I am in town visiting LVC for graduate courses, so I decided to make this my first lunch stop for the summer. For the price, I was expecting a little more....read more
- bedrooms 1
- rental type Apartment
- owner badge
- sleeps 4
- baths 1
- rates (USD)
$805 /wk
- bedrooms 4
- rental type Cottage
- sleeps 10
- baths 2½
- rates (USD)
- $200
$925 - $1,250 /wk
$4,000 /mth
- bedrooms 7
- rental type Barn
- owner badge
- sleeps 26
- baths 7
- rates (USD)
- $1,200
$4,500 /wk
- bedrooms 3
- rental type Cottage
- owner badge
- sleeps 6
- baths 1
- rates (USD)
- $125
$675 - $725 /wk
$2,850 /mth


text:
Imagine driving an open-air Model T wearing an all-weather duster and goggles in a time without reflective road signs, center lines or even a reliable arrival time at your destination. If you ventured out in the country, chances are you traversed log roads, dirt roads, cow paths and abandoned stagecoach lanes. Now imagine doing that with two wooden legs, a wooden arm and hand, and only a thumb on the other hand, without power steering!
That was the audacious goal of Michael Dowling, an auto dealer from Olivia, MN, who lost his limbs from frostbite as a child, and who also was a teacher, newspaperman, banker, legislator and World War I inspirational speaker. In 1913 he led a three-car caravan as the first to traverse the fledgling 3,700-mile Yellowstone Trail, from Puget Sound, WA, to Plymouth Rock, MA, and right through Hudson.
Armed with early auto guides giving directions such as "straight thru across RR on good graded dirt," Dowling was lucky when he was guided by painted yellow rocks or black arrows in yellow circles on fences, telegraph poles, silos, barns or other buildings pointing the way along the transcontinental trail.
Hudson's Yellowstone Trail Heritage Days
Like those that once lined the Yellowstone Trail, painted rocks and yellow signs with black arrows will mark Hudson's Second Annual Yellowstone Trail Days, May 13-15. Visitors can explore the era with car runs along the trail plus historical tours, a car show, stage show, high wheel bike demos, a carnival, strolling musicians, an architectural treasure hunt, author appearances and more.
"Last year the initiative was to get the Yellowstone Trail marked with signage," said Andrea Jorgenson, director of communications and programs at the . The original trail runs from the old toll bridge road (also known as dike road) to Third and St. Croix streets and on to County Road A and U.S. Highway 12, but a route from Vine Street/County Road UU to Jacobs Lane and U.S. Highway 12 was adopted in 1919.
Jorgenson said that interest and enthusiasm in this year's event is very high.
"It's now a regional event with many other communities participating over the summer," she said. "The goal is to get it nationally recognized as a historic byway. Next year is the 100th anniversary of the trail so we expect it to become even bigger."
The Road's Back Story
One of the first transcontinental roads, the Yellowstone Trail began in 1912 when South Dakotans successfully advocated a national, northern county-to-county citizen road-building effort in either direction. The idea took hold; in 1913 the ferry across the St. Croix River to Minnesota at Hudson was replaced by a toll bridge as rapid advances in automobile technology allowed more and more citizens to become mobile in a new way.
"Get out of the mud!" became the rallying cry for this national road effort. The Yellowstone Trail bisected Wisconsin from 1915 to 1930, and the state was the first in the nation to number its roads in 1918 and possibly the first region of the the world to do so, according to Introducing the Yellowstone Trail authors John and Alice Ridge. The Ridges are officials with the Yellowstone Trail Association and speaking and book-signing at Octagon House events Saturday noon-4:30 pm.
A self-guided tour guide, Driving the Yellowstone Trail detailing the historic route from Hudson to Kenosha, is available at the event. Like others along the trail, some businesses in Hudson named their establishments after the Yellowstone Trail and subsequent roadways in the hopes of attracting the new breed of auto tourists. was once called the Yellowstone Trail Buffet, the was called the Yellowstone Cafe, and was called Trail 12 after the numbering system was adopted. The U.S. Numbered Highway System began in 1926, and the Yellowstone Trail eventually became U.S. Highway 12.
A Yellowstone Trail-Era Road Sign
Local historian Lorraine Jacobs has an early gas station/directional sign, likely from the Yellowstone Trail era, that was given to her late husband Bob, by the late James "Eddie" Smith decades ago. Smith purchased a farm on U.S. Highway 12 and County Road A/UU where a tiny gas station along the Yellowstone Trail was located. Jacobs Lane, an early part of the Yellowstone Trail, was named for Bob's family who farmed the area.
"The gas station was really just a lean-to with a roof over the tank and pump with a shed for cars at what was known as 'Batten Corner' on U.S. 12," Jacobs said. "It was a dangerous corner where there were many accidents."
The 12-foot tall narrow wooden sign is painted with a red arrow on top and notes "9 miles to Roberts" on one side and "31 miles to Minneapolis" on the reverse. The sign is an advertisement for Litening gas, which was likely sold at the stop. Some information on Litening Gas Co. in Bozeman, MT, can be found on the message boards on the Primarily Petroliana website and a Montana Litening station is listed on the National Register of Historic Places.
Jacobs said she hopes to eventually donate the sign to a historical organization that will restore, preserve and display it.
"It would be interesting to research why the sign notes Minneapolis, and not St. Paul," she said.
Yellowstone Trail Heritage Days highlights
Friday, May 13
6-8 p.m., Locust St. Car Show
Saturday, May 14
8:30-10:30 a.m., Historical geocaching, Dick's Bar
10 a.m.-2 p.m., Car show, Old Toll Bridge Road/Beach House Lot
10 a.m.-2 p.m., Yellow rock painting, Associated Bank
10 a.m.-4 p.m., Casanova Cave tours, Nova Wine Bar
11 a.m.-2 p.m., Olde-Tyme Market Fair/strolling musicians/vintage high wheel bikes/carnival, Locust Street
11 a.m. & 1 p.m., Barry Prichard, author/grandson of Yellowstone Trail pioneer Michael Dowling, "We Blazed the Trail," Hudson Library
Noon & 2 p.m., Cemetery & residential history tours
Noon-2 p.m., Afton-Hudson Lunch Cruise, Old Toll Bridge Road ( tickets)
Noon-4:30 p.m., John and Alice Ridge, authors, "Introducing the Yellowstone Trail," Octagon House
Noon-4:30 p.m., Octagon House tours/history booths
1 & 3 p.m., Downtown history walking tours
2 p.m., Classic Car Sociability Run, Beach House Lot to Hammond with special "retro" menu at the Hammond Hotel for participants
7:30 p.m., Fiddle Master Randy Sabien & his Fiddlehead Band, The Phipps Center for the Arts ( tickets)
Sunday, May 15
Self-guided driving tours


text:
A few months ago my son and I rode the local trolley. Though it is designed to be for tourists, I thought it would be cool to see some of Albuquerque I might not have seen. One of the places we went was the neighborhood where a lot of movies are filmed. Movies that don't say they are in New Mexico, but places like Seattle and California. So yesterday I decided I wanted to work on my wheels and entries sets and that neighborhood would be a great place to go. As we were on our way there we passed Tingley Beach. A series of ponds created in the 30s for swimming. Now they are primarily for fishing. No swimming allowed. But they now sport Pedal (I always thought it was paddle) Boating. Mr B and I took a ride. Tough work, pedal boating. I found all of this week's prompts at the beach and in the neighborhood I went driving through, just like they did in the movie Wild Hogs.
WhiteIsn't it fun? Just parked in a driveway waiting for me to take the picture. The mouth was there, my watermark just makes a perfect "nose".
PlayWe didn't ride on that one. We went on the one like the next photo, with a cover on it. It was pretty warm out.
SparkleThe pedal boats were glittery but since you can't tell I chose this for the way the sun sparkles on the water.
I had in my head that play was patriotic so I think it fitting this weekend to add that one anyway.
Of course I have only looked at houses for a week, but I am a little worried. I showed you pictures of what my other house looked like. It is only 10 years old and I was the second owner. Still am technically. The first mortgage company I called said I couldn't get another mortgage until my other house had been under contract for a year (really 12 payments had been made). Well that really put a damper on things. I already have to rely on my parents enough as it is, I didn't want a co-signer on my 4th ever house. My heart fell a little. At that time I had also already walked through like 10 houses. 10 gross houses. I knew I was going to have to do some work on a house, with my price range, but I wasn't prepared for what I saw in houses that were actually higher than my price range. And the smell in some of them. And these weren't houses under 100k.
My brother and sister in law are in the midst of flipping a house. Maybe a little bigger than they should have started on their first house. It is taking them forever. I am worried for them too. A LOT of houses have gone up for sale on the street behind them. The street that literally backs up to the golf course. So yesterday we all went to look at this house. Only $57 a square foot. Considering all the other houses in this neighborhood, the neighborhood where I want to live so my son can walk to school, range around $100 a square foot. We had to go see why it was so low. Pro: the steeped, tiled roof right at the front. The closed-in sun room right at the front, with a great view of the mountains. There is no house across the street so you have a wide open view of Corrales and the mountains. That is where the pros stopped. The house would literally have to be gutted. The garage (where the board is on the left) was turned into an apartment, but never fully finished. Which was odd since it looked like it was done in the 70s. The pool in the backyard was only cinder block so easily could be filled in, and the porch looked like it was off of an old trailer park house. It had potential, if your budget wasn't the price of the house. Some flipper needs to come in and gut it.
Then my brother tells me to be patient. Give myself 6 months. Right. I used a POD to store my belongings (except valuable and breakable) in and can't afford that thing for more than 3 months. I don't feel I need to be rescued, but I could use that man riding up on a white horse right about now (years ago really). This trying to do life alone is no fun.
I am using these photos straight from my phone so I hope they aren't bad. As I finished cleaning out my house today I took some last photos. It was bittersweet. As I said before, I loved this house. I loved the open kitchen with lots of cupboard space.
This picture wasn't today. I guess I missed it. But there it is anyway.
The laundry room wasn't bad either. At least it wasn't a closet. I would have liked a door in a different spot tho. My first (town)house had the washer in one spot and the dryer under the stairs across from it. In Austin, my cute little house had them in the garage.
This is what the space looked like after I put the cupboards up. Here is a before redo
I got organized after that too. Just in case the cupboards didn't go up.
I loved the vaulted ceilings (see kitchen). The arched doorways. The fan I put in the living room and the wood floors my parents put in. And the closet space was awesome.
Have you ever tried a recipe and knew that you would make that many more times to come? I HATE bananas. But I like some banana nut breads. Warm with butter. I LOVE Biscoff Cookie Spread. I don't live close to a Trader Joes so I have never tried their brand. When I came across this banana bread recipe with Biscoff, of course I had to try it.
Didn't have to eat them warm.
Didn't have to spread butter on them.
Just pulled out of the tupperware and ate them. Took them to work several times and I keep getting asked for more.
Thank you Maria at Two Peas and Their Pod for this great recipe. I, of course, added nuts though.
Biscoff Banana Nut Muffins
1 1/2 cups of all-purpose flour
1/2 tsp baking soda
1 1/2 tsp baking powder
1/2 teaspoon ground cinnamon
1/2 teaspoon salt
3 medium very ripe bananas, mashed
1/2 cup Biscoff Spread
1/4 cup oil
1 large egg
1/2 teaspoon vanilla extract
1/2 cup granulated sugar
1/4 cup light brown sugar
For the Biscoff Cookie Streusel:
1/2 cup chopped Biscoff cookies
1/4 cup chopped pecans
2 tablespoons all-purpose flour
1/4 cup brown sugar
1/8 teaspoon ground cinnamon
3 tablespoons unsalted butter, melted
1. Preheat oven to 350 degrees. Grease or line muffin pans and set aside.
2. In a medium bowl, whisk together the flour, baking soda, baking powder, cinnamon, and salt, set aside.
3. In a stand mixer, mash bananas. Add the Biscoff Spread, oil, egg, vanilla, and sugars.
4. Add the dry ingredients into your wet ingredients and mix until just combined. Batter will be slightly lumpy, don't over mix.
5. Scoop batter into prepared pans.
Make streussel:
1. In a small bowl, melt butter. Combine chopped Biscoff cookies, chopped pecans, flour, brown sugar, and cinnamon to the melted butter. Stir until combined. Add a spoonful of the streusel to the top of the batter in each muffin cup.
2. Bake muffins for 35-45 minutes or until toothpick inserted into center comes out clean.
Enjoy warm or straight of the tupperware.
Linking to these great parties:
The Creative Collection Link Party
I cannot get a good picture of my redone bathroom. My Nikon won't get a smaller picture and my iPhone pics are coming out grainy. Ick. Here is my bathroom before (but a little into the work).The arrow above…see that corner now.
With my parents' help we got the beadboard and molding up with liquid nails and a few nails through the nail gun (the beadboard is also on the side of the cabinet). Then I put up new baseboard pieces behind the toilet. And look, that corner doesn't look unfinsihed at all. I had never used caulk before this room and I think I ended up doing a good job. I finished painting the walls that lovely milk chocolate color and then painted all the wood in the room that off white color (same color in the kitchen). Added some hooks, the door and drawer pulls, and put jute on all the bottles. The towels are from Sam's Club and ended up being the perfect color. Previously, I had also spray painted the ceiling vent because it was so rusted. All in all; since I bought this house, I have replaced the toilet, the mirror, the light fixture, the sink faucets and the door knob. I put in one of those curved shower curtain rods that keep the shower curtain from touching oneself while in the shower. I have painted it twice and now added the beadboard.
I linked to these parties: Strut Your Stuff Saturday and The Party Bunch
I love my house. My parents put in wood floors before my brother and his family moved in and I really love my house. Nice size. Lots of closets. Bigger backyard. But it is way out here and my family lives in the middle of the city. My son doesn't want to change schools and leave his friends and I go to work REALLY early in the morning. I need a little bit lower mortgage and to live where he can walk to school next year (and have nana and papa in a close enough distance in case of emergency). So the realtor came over on Sunday the 4th. We planned on him putting up the sign on the 24th and listing it on MLS. My garage needed organizing and I needed to finish cleaning up the backyard. Maybe some little painting (like on the garage door trim). He went home and told his broker about my house. He in turn had people that wanted to see it. They looked at it on Tuesday and made an offer on Wednesday. I signed the contract on Thursday and have to be out of here on the 29th. WOW. I wasn't expecting it to be that quick. Bittersweet. On the bright side, I don't have to make sure my house is ready to show every morning before I leave for work. :)
I am most likely going to get a house that needs some work. But I look forward to the challenge and hope that it ends up being a house I can live in for years to come. And I now have a little practice on some of the things I would like to be able to do. I would go a different route on painting the cabinets though. It was really tough not to get the drip marks on the corners.
I also wanted to share my spring mantel with you. This was my mantel basically all winter. I use the picture because it was either my grandmother or grandfather's. Brought from Japan. But I never realized how dreary it really was.
The picture isn't as bad with some color under it. Not sure I will hang it up again in my new house though. I think I will print something else that I took, and put that in the frame. The IBC bottle is something I spray painted for Mr B's birthday party. The butterfly out of a box for girly decor for the crafts I was doing. The blue glass I just painted. It was cool to just squirt paint in glass bottles and turn them upside down and get that.
This bowl? If that is what you can call it. It is wood, I picked it up at a thrift store forever ago. I found it in the garage in one of my semi-finished projects boxes. I had painted it before putting it in the box. This is the first time I have ever used it. Went good with the bunny. The candle I had, I just added the pieces of Washi tape.
Stay tuned for my updated bathroom and laundry room posts.
This school year (4th grade) my son has played soccer in the fall and spring, basketball in the winter and now is in track. Last week was a yucky first track meet day. Cold. Windy. Tried to snow but was too windy. Snowed on the mountains as you can see above. A rather unorganized school hosting. Cold. Windy. Poor kids and their tiny uniforms when they had to take their layers off.
My son is working on the long jump and the mini javelin as well as running. I never knew there as a mini javelin. It looks like a huge plastic dart.
That's all my little man wore all day even though I was still freezing with gloves, ear muffs, a hoodie and a jacket and a blanket wrapped around my legs.
Boy, is he getting tall. Those long skinny legs. He is 10. But because his birthday is 2003, he falls in the 11-12 year old bracket and competes against boys that have been in that bracket for 2 years already. He started practicing with spiked shoes this week and I hope to see a big improvement tomorrow. Especially in the weather and temperature.
On another note. The other day I wanted to do something with my Easter eggs instead of just eat them with salt. I had never had Egg Salad so looked it up.
In my Ninja, I used:
2 hard boiled eggs
1/2 ripe avocado
salt and pepper to taste
good squirt of Jalapeno Mustard
I only had pretzel rolls and no lettuce so I put dill pickle thins on the roll and topped it with the egg salad. It was really good but next time I will put it on Whole Wheat bread, try lettuce and make sure I don't over chop in the Ninja when I have to go back and add the mustard.
Linking to:
The Creative Collection link party
TrickLittle egg blended in with the flowers.
Selective ColorI was glad for this prompt. I couldn't figure out what it was called when you left one color in a black and white photo and wanted to do that to this photo. So I looked up how to do selective colors.
MirrorHere is a peek into my newly refinished bathroom. One more drawer handle to install and I will reveal the whole room. I LOVE it.
I am always looking for new places to take pictures. When I am always doing the driving, this can sometimes be harder than it would seem. When I saw an ad for a trolley ride around the "best of Albuquerque" I hopped on. Albuquerque, pronounced AL-bu-kur-key, is a desert city. With very slight weather changes, it is a great place to be. But still a smallish large city. Not a very big airport at all, but the only major airport in New Mexico. I would bet that 90% of you have never heard of Albuquerque. And another large number of you don't know New Mexico is one of the 50 states (I used to be a flight attendant. You might be shocked at the remarks I used to get.)
Mr B had fun on the trolley. It was a good little adventure and I learned some things about Albuquerque I didn't know. For instance, the movie Wild Hogs? Picture it. Picture them all meeting up on their motorcycles, riding down the street and William H. Macy crashing into a street sign (somewhere Seattle it claims in the movie). Then they go into a Seattle biker bar. That whole part was filmed in Albuquerque. Anybody that watches Breaking Bad knows that it was filmed in Albuquerque. I personally have never watched it, I am more a In Plain Sight (also filmed here) kinda gal. The trolley guys even have a whole Breaking Bad tour. I am sure that didn't hurt their business any. But what a cool job. Driving people around in a trolley, showing them the good stuff.
Famous Route 66 goes right through Albuquerque. A main street that is now called Central. Parts of Central you are told not to be on after dark, but the majority of the street is what makes up downtown, Uptown, the student strip of UNM and the entrance to Old Town. There is some real great stuff off of Route 66. There are some awesome older buildings that developers have come in and fixed up and turned into something else. For instance, the original Albuquerque High School is now lofts. What used to be a mental hospital (right off of the freeway) sat empty for several years and is now an upscale hotel. Once upon a time, I now can't remember what building it was, some old building was torn down. Now there is a law that certain buildings can't be torn down. So the original drive up motel on Route 66 sits boarded up. Some developer bought it and was going to tear it down to put up lofts and the mayor at the time had it declared an historic landmark. The original neon sign was finally removed to put in a museum and the rest of the building (not crumbling or anything) sits boarded up, waiting its what can we use this for fate.
Fun fact. Although New Mexico does not have any major league sports teams, Albuquerque does have a minor league baseball team. When the Duke's franchise moved to Portland and a team from Calgary relocated here, they took a poll from the city to see what to call the new team. The people of Albuquerque unanimously voted for the Isotopes. What are isotopes and what do they have to do with New Mexico? Isotopes are some nuclear thing and tho Los Alamos, New Mexico is where the atomic bomb was produced, but this wasn't the reason for the name of the team. At least not by the people that voted. A few years before the team was in question, there was an episode on The Simpsons. Homer had a hunger strike because he found out they wanted to move the Isotopes baseball team to Albuquerque. So the voters made it actually happen a few years later.
I had said earlier that there is an act that buildings can't be torn down. In the background of this photo is Downtown Albuquerque and the tallest building in the state. No need to build up here, there is plenty of room to build out. The buildings in the front of the photo are part of the Barelas railyard shops which have been closed since 1970. They are pretty vandalized buildings and completely empty. I noticed it would be a great place to use for a backdrop for photos. But the reason these buildings are rebuilt as lofts of anything is because they make lots of money in movies. Movies filmed in the vacant railyard complex include Beerfest (2006),Terminator Salvation (2009), The Avengers (2012), and the pilot episode of Terminator: The Sarah Connor Chronicles. The trolley guys said there is a scene from Transformers (where Bumblebee and a Decepticon crash into a railyard) filmed here too, but I couldn't find anything that collaborated this.
Neil Young and the Partridge Family sing songs about Albuquerque. Tim McGraw and and Glen Campbell mention Albuquerque in a song. Even Bugs Bunny, while traveling around the world by burrowing underground; would often get lost while traveling and remark, while consulting a map, "Should have made a left toin at Albukoykee". All three High School Musical movies are set in Albuquerque, at the fictional Albuquerque East High School (but not really filmed here). Microsoft began on April 4, 1975, when it was founded by Bill Gates and Paul Allen in Albuquerque. Demi Lovato was born here. Neil Patrick Harris and Freddie Prinz Jr went to high school here. Jesse Tyler Ferguson from Modern Family was raised here. Here being Albuquerque but how many times can I say that word in this entire post? LOL. Albuquerque Studios is the largest production facility in the country and have filmed over 600 movies in New Mexico. The new movie Transcendence that came out yesterday, was filmed here. As well as Lone Survivor to name a few.
Tho the wind may blow a lot, it is the desert, and sand with that wind, the climate is pretty ideal. In the spring there is some green grass, pretty flowers and blooming trees, but gotta watch out on overusing water. We don't get a whole lot of rain but that is why so many movies are filmed here too. I don't live in Albuquerque, but Rio Rancho is part of the metro area. I have lived here longer than I have lived anywhere else. I by no means am being paid by anyone for this post, just something I wrote after my adventure yesterday. I do find it to not be a meet a man kind of place, and not very single mom friendly. But there are worse things in life. My son likes it here, my family is here and I find great places to take pictures (just not in winter). I would really love to find a good meet-up photography group but it must not be a big thing around here outside of Balloon Fiesta. Hum I have a thought…something along the lines of the trolley and photography meet-ups. Wonder what way to start a business like that. Scooter rental tours?
Greetings from New Mexico. I live right next to and work in the biggest city in the state. I started blogging in 2009 when I learned to share my crafts. I quickly learned I needed a better camera and got my Nikon d90. I then learned that I loved sharing my photography and changed the focus of my blog to just that. I also moved over to Wordpress and became Sanukipity Photography in 2011. Recently, I started baking. A wonderful new passion. A great stress reliever. And another thing to photograph and share. Welcome to my open world of finding fun and happiness thru the lens.


text:
Weston Football Club
- Nickname:Seagulls
- Founded:1887
- Manager:
- Ground:Woodspring Park
- Capacity:0
- Last Game: 09-Oct-2010 15:00
- Salisbury City
- Full match report
Club History1887-88 The first record of a Weston-super-Mare side was when they lost to Clevedon Town in a medal competition organised by the Somerset FA. The following year they Weston were members of a County Committee of the Somerset FA. 1911 Weston won their first cup when they beat Clevedon Town 3-0 in the Weston Charity Cup. The Seagulls also entered the FA Cup for the first ever time. 1913-14 Weston finnished third in the Bristol Charity League behind Bath City and Bristol Rovers Reserves. 1922-23 Weston played in the Bristol and District League coming second behind Bristol Leather Trades. Weston also won the Bristol Charity Cup. 1926-27 Weston won their third ever cup defeating Paulton Rovers in the Semi Final after starting with nine men because two players had been sent bogus telegrams advising that the match was off. Weston defeated Welton Rovers in the Final in front of a 6,000 crowd. The Seagulls were also finalists in the Clevedon Charity Cup losing to Clevedon in the final. In those days Weston players paid 6/6d to play (thats twelve and a half pence). 1948 Weston Football Club reformed after World War Two and entered the Western League. 1950s The Club spent most of this time in the Western League Division Two going close to promotion on a couple of occasions. The club moved from the Great Ground in Locking Road where they regulary attracted crowds of over 1,000 to Langford Road. 1961-62 The club reached the first round of the FA Cup, but were beaten by local rivials Bridgewater Town in the last minute in a replay, in front of a home crowd of 2,500, This defeat ment the club missed out on a home tie against Crystal Palace. 1982-83 Weston moved to their present ground Woodspring Park, the ground itself was built almost entirely by supporters.
Latest Reader Comments
"who wrote this trashy piece of so called journalism? " I can promise you, he would never consider another move to the Stadium Of Shite" not big or clever, im sure Lee Clark wouldnt appreciate such comments made on his behalf."
DaveLee Clark not interested in Sunderland job
"We knew this was going to be one of those games. But the whole affair was marred by a referee who clearly seemed to have lost the plot on more than one occasion. Sorry ref!! But my rating for your performance has to be a paltry 0 "
GazTempers flare in derby draw
"We knew this was going to be one of those games. But the whole affair was marred by a referee who clearly seemed to have lost the plot on more than one occasion. Sorry ref!! But my rating for your performance has to be a paltry 0 "
GazTempers flare in derby draw


text:
double trouble map
Comments : 2
Join us to post comments.
1 - 2 of 2
1 - 2 of 2
Join us to post comments.
1 - 2 of 2
1 - 2 of 2
FragVoice.net Launch! (1)
Started 08/20/2014/
AzroWear said 08/20/2014/
Hello! 4.8Advertising External Websites/Commercial Advertising The use of the Planet Minecraft to ob...
Started 08/20/2014/
ioXLRoi said 08/20/2014/
can anyone help me?...
Need Help with App! (0)
Started 08/20/2014/
GildedGam3r said 08/20/2014/
So, I want to create an app for my engineering and biology class. I want to make it so you have to r...
What are your thoughts on the ebola virus pandemic(NO KIDS!) (12)
Started 08/20/2014/
Foxy said 08/20/2014/
Normally I'd be saying things like "oh the media is blowing things up again" but we studie...
Do you believe in extraterrestrial beings/Aliens? (126)
Started 08/20/2014/
SasukeUchiha2214 said 08/20/2014/
Of course they exist, have you ever heard of illegal immigrants? I was waiting for someone to bring...
How do I become a moderator? (7)
Started 08/20/2014/
AquilaeVolanti said 08/20/2014/
http://www.planetminecraft.com/rules/#how_do_i_become_moderator this. and also that satan pact help...
What is your opinion on gay marriage (1)
Started 08/20/2014/
KnobleKnives said 08/20/2014/
Locked. This is a Minecraft website, not a site for the discussion of sexual orientation....
Shading Template! (0)
Started 08/20/2014/
julian361 said 08/20/2014/
Shading Template: ? This is to those who are looking for a shading template! ? Here's my first post,...
Deadfrost Online (2D MMO I'm making) (122)
Started 07/27/2014/
MissMarifire said 08/20/2014/
It seems like a pretty interesting game. The only problem I have is the color palette; it's very bla...
Free Website Hosting (16)
Started 08/20/2014/
XxkillazombiecowxX said 08/20/2014/
Looks interesting...
I need your help Exporting my mod to minecraft (1)
Started 08/20/2014/
steewped said 08/20/2014/
Why don't you ask the person that made it? Sounds like you don't have a clue and have done zero rese...
Looking for a gif server banner designer :) (3)
Started 08/20/2014/
ArcaneNath said 08/20/2014/
ill think about it Awesome! ...
Who's excited for Series 8 of Doctor Who!? (25)
Started 08/20/2014/
SpiderMatty8 said 08/20/2014/
Gotta finish season 7...
Denizen's anyone do any mods with it? (0)
Started 08/20/2014/
steewped said 08/20/2014/
I'm bored and I'm messing around I happen to have free hosting of 40mbits up and down and have a ubu...
Skin requests are open! (1)
Started 08/20/2014/
Korgad said 08/20/2014/
Awesome! I would like a Viking esc man with an eyepatch and a scar on "his right" eye. I w...
|People Online
|Total Members
|Minecraft Submissions
|Total Submission Views


text:
40+ Presenting Companies Conducting 100+ Clinical Trials with 25+ Products Already on the Market!
The 4th Annual Partnering Forum at Stem Cell Meeting on the Mesa includes a pipeline loaded with partnering opportunities. Collectively, the initial slate of 40+ presenting companies are conducting 100+ clinical trials with an additional 135 studies currently in the pre-clinical phase – not to mention their 25+ products already on the market! Altogether these companies are working on 150+ unique products with an extensive range of possible therapeutic applications. With 10+ hours of presentations over the course of two days, this meeting provides attendees a unique opportunity to forge collaborations with regenerative medicine's top industry leaders.
Quick Links
2014 Company Presenters
Dominick Colangelo, President & CEO
Oct. 7 | 10:15am | La Jolla Ballroom 1
Ann Arbor, MI
Founded in 1989, Aastrom Biosciences is dedicated to the development of stem cell treatments for critical cardiovascular diseases. Aastrom is currently evaluating its autologous cellular therapies in U.S. clinical trials in the treatment of dilated cardiomyopathy (DCM). These critical diseases are associated with significant morbidity and mortality and very limited treatment options. www.aastrom.com
Dan Menichella, Chief Business Officer
Oct. 7 | 2:15pm | La Jolla Ballroom 1
Alachua, FL
AGTC is developing cures for rare lung and eye diseases, offering hope to patients with unmet medical needs. With a highly specialized team of physicians and researchers, the Company is use cutting-edge techniques to develop treatments for patients that have diseases caused by broken genes. AGTC uses AAV gene therapy, which replaces those broken genes with normal functional genes, allowing a patient's own body to produce proteins to treat their illness. A single injection provides long-lasting treatment, leading to a better quality of life for patients worldwide. www.agtc.com
Gil Van Bokkelen, Ph.D., Chairman & CEO
Oct. 7 | 11:45am | La Jolla Ballroom 1
Cleveland, OH
Athersys is a clinical-stage biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life. The Company's focus is on the treatment of medical conditions where there is significant unmet clinical need. Athersys is developing MultiStem®, a patented, adult-derived "off-the-shelf" stem cell product platform for multiple disease indications in the areas of inflammatory and immune, neurological and cardiovascular disease. The Company has two ongoing clinical studies – a Phase II study in ulcerative colitis being conducted with Pfizer and a Phase II study in ischemic stroke – and overall five clinical-stage programs in inflammatory bowel disease, stroke, graft-versus-host disease, acute myocardial infarction and solid organ transplant. Athersys has forged a network of strategic alliances and collaborations with leading pharmaceutical and biotechnology companies, as well as world-renowned research and clinical institutions, in the U.S. and Europe to further develop its platform and products. www.athersys.com
Hans Hull, SVP, Legal & Corporate Development
Oct. 8 | 2:00pm | La Jolla Ballroom 1
Menlo Park, CA
Avalanche is a clinical-stage biotechnology company focused on discovering and developing novel gene therapies to transform the lives of patients with sight-threatening ophthalmic diseases. Using a next generation gene therapy platform, the Ocular BioFactory™, the Company is developing products designed to provide long-term benefit or a functional cure by inducing a sustained expression of a therapeutic protein with a one-time administration in the eye. www.avalanchebiotech.com
Caleb Bell, Ph.D., CEO
Oct. 7 | 5:15pm | La Jolla Ballroom 2
San Francisco, CA
Bell Biosystems is pioneering the use of synthetic organelles to accelerate product development in regenerative medicine and oncology. Organelles are nature's way of adding functions to cells and Bell Biosystems has discovered a way to make synthetic organelles to add new, useful functions to cells. The Company's first organelle, the Magnelle, is a living magnetic resonance imaging contrast agent that can divide with cells. Using non-invasive MRI, researchers and companies can image and track Magnelle labeled cells and cell progeny longitudinally because Magnelles do not dilute like traditional MRI contrast reagents do during cell division. This technology can enable tracking of cell engraftment, distribution and persistence, and therefore monitor safety and efficacy of cell therapies. www.bellbiosystems.com
Mike Rice, CEO
Oct. 8 | 2:15pm | La Jolla Ballroom 2
Bothell, WA
BioLife Solutions develops, manufactures and markets hypothermic storage and cryopreservation solutions and precision thermal shipping products for cells, tissues and organs. The Company's proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the regenerative medicine, biobanking and drug discovery markets. BioLife's biopreservation media products are serum-free and protein-free, fully defined and are formulated to reduce preservation-induced cell damage and death. The Company's enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues and organs. BioLife also performs contract aseptic media formulation, fill and finish services. To date, the Company's proprietary biopreservation media products have been incorporated into over 100 hospital-approved and clinical trial stage regenerative medicine products and therapies. www.biolifesolutions.com
Faraz Ali, Vice President, Commercial Development
Oct. 8 | 1:30pm | La Jolla Ballroom 1
Cambridge, MA
bluebird bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases. bluebird bio has two clinical-stage programs in development. The most advanced product candidate, Lenti-D, is in a recently-initiated Phase II/III study, the Starbeam Study, for the treatment of childhood cerebral adrenoleukodystrophy (CCALD), a rare, hereditary neurological disorder affecting young boys. The next most advanced product candidate, LentiGlobin, is currently in two Phase I/II studies, one in the U.S. (the Northstar Study) and one in France (HGB-205), for the treatment of beta-thalassemia major. The Phase I/II HGB-205 study also allows enrollment of patients with sickle cell disease, and bluebird bio is planning a separate U.S. sickle cell disease trial (HGB-206). www.bluebirdbio.com
Linda Marbán, Ph.D., CEO
Oct. 7 | 10:45am | La Jolla Ballroom 1
Beverly Hills, CA
Los Angeles-based Capricor Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of regenerative medicine and large molecule products for the treatment of diseases. Capricor's lead product candidate, an allogeneic cardiosphere-derived cell (CDC) product, CAP-1002, aims to attenuate and potentially improve damage to the heart caused by a heart attack and is currently under evaluation in the Phase I/II ALLSTAR clinical trial of patients 30-days to 1-year after a heart attack. Additionally, Capricor plans to explore development of exosome technology as a next generation regenerative medicine platform in a variety of cardiovascular and non-cardiovascular areas. Groundbreaking preclinical research has demonstrated that exosomes extracted from Capricor's CDCs reduced scar tissue caused by a heart attack and prompted myocardial regeneration in preclinical models of ischemic heart disease. www.capricor.com
Christian Homsy, CEO
Oct. 7 | 11:00am | La Jolla Ballroom 1
Mont-Saint-Guibert, Belgium
(CARD:EN Brussels)
Cardio3 BioSciences is a leading biotechnology company focused on the discovery and development of regenerative and protective therapies for the treatment of cardiac diseases. The Company's lead product candidate, C-Cure®, is a highly innovative stem cell approach for the treatment of heart failure, one of the world's most pressing unmet medical needs. Generated through a proprietary technological platform, the C3BS-CQR-1 programme is designed to direct the patient's own stem cells into new heart cells with the potential to rebuild the heart. Cardio3 BioSciences has also developed C-Cath®ez, the most technologically advanced injection catheter with superior efficiency of delivery of bio therapeutic agents into the myocardium. Cardio3 BioSciences was founded in July 2007 and is based in Mont-Saint-Guibert in the Walloon region of Belgium. The Company leverages research collaborations in the U.S. and in Europe with Mayo Clinic. www.c3bs.com
Clive Svendsen, Ph.D., Director & Professor, Board of Governors Regenerative Medicine Institute
Oct. 8 | 4:30pm | La Jolla Ballroom 2
Los Angeles, CA
(Non-Profit Hospital)
Regenerative medicine is a new and developing field that aims to restore function in diseased or aged tissues through either revitalizing existing cells, or the transplantation of new cells-stem cells. These cells are of great interest to regenerative medicine. They lie deep within most tissues of the adult body, but are often difficult to manipulate or expand outside the body. Induced pluripotent stem (iPS) cells are stem cells from the adult human body that have been reprogrammed back to an embryonic stem cell state. These are important for regenerative medicine as they can be derived from a single patient, turned into any tissue of the body and then used as a source of autologous cells for repair – thus avoiding immune rejection issues and may be used as novel and important models of human disorders. The use of iPS cells is not burdened with the ethical issues associated with human embryos. www.cedars-sinai.edu
Krisztina Zsebo, Ph.D., CEO
Oct. 8 | 4:15pm | La Jolla Ballroom 1
San Diego, CA
Celladon is a clinical-stage biotechnology company developing novel therapies for diseases with tremendous unmet medical needs. The Company's lead gene therapy product candidate MYDICAR® targets calcium dysregulation in cardiomyocytes by increasing SERCA2a enzyme levels in advanced heart failure. In a placebo controlled Phase IIa trial, MYDICAR® demonstrated an 88% reduction of hospitalizations for heart failure and a trend in improved overall survival. Benefit in clinical outcomes was also supported by improvement in patients' heart failure symptoms, exercise tolerance, serum biomarkers and cardiac function. MYDICAR® recently received Breakthrough Therapy designation by the FDA, and the EMA indicated that if MYDICAR® demonstrates a substantial and highly significant treatment effect, and no untoward effects attributable to MYDICAR® are observed, a safety database of approximately 205-230 MYDICAR® treated subjects may be sufficient to allow for acceptance of an MAA. MYDICAR® is currently in a 250-patient Phase IIb trial with results expected in April 2015. www.celladon.com
Robert Palay, CEO
Oct. 8 | 4:30pm | La Jolla Ballroom 1
Madison, WI
Cellular Dynamics International is a leading developer of fully functional human cells derived from induced pluripotent stem (iPS) cells. The Company's iCell® and MyCell® product lines provide industrial quantities of high quality, highly pure human cells enabling disease modeling, drug discovery, toxicity testing and regenerative medicine research. www.cellulardynamics.com
Matthew Plavan, CEO
Oct. 7 | 2:30pm | La Jolla Ballroom 2
Rancho Cordova, CA
Cesca Therapeutics is engaged in the research, development and commercialization of autologous cell-based therapeutics for use in regenerative medicine. The Company is a leader in developing and manufacturing automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products. www.cescatherapeutics.com
Koji Kuchiishi, Chairman, President & CEO
Oct. 7 | 11:00am | La Jolla Ballroom 2
Tokyo, Japan
Founded in 2010, Cyfuse Biomedical K.K. is a Japan-based start-up focused on scaffold-free 3D tissue engineering. Cyfuse successfully developed the bio 3D printer Regenova, a state-of-the-art robotic system that enables fully automated fabrication of three-dimensional artificial tissues from living cells. The Company's goal is to facilitate innovative therapeutic approaches through new bioengineering technologies to make regenerative medicine a reality for patients around the world. www.cyfusebio.com
Martin Rosendale, CEO
Oct. 7 | 5:45pm | La Jolla Ballroom 1
Gaithersburg, MD
Cytomedix is an autologous regenerative therapies company commercializing innovative platelet technologies for wound care. The Company markets the AutoloGel™ System, a device for the production of autologous platelet rich plasma (PRP) gel for use on a variety of exuding wounds. www.cytomedix.com
Marc Hedrick, M.D., President & CEO
Oct. 7 | 11:30am | La Jolla Ballroom 1
San Diego, CA
Cytori Therapeutics is a cell therapy company dedicated primarily to the development of novel treatments for cardiovascular disease and soft tissue injuries and burns. The Company has a global product development strategy focused on the U.S. cardiovascular disease market. In the U.S. Cytori's goal is to bring cell therapy to market for treatment of chronic ischemic heart failure through Cytori-sponsored clinical development efforts and to develop a treatment for thermal burns combined with radiation injury under a contract from BARDA, a division of the U.S. Department of Health and Human Services. www.cytori.com
Flagg Flanagan, Chairman & CEO
Oct. 7 | 11:30am | La Jolla Ballroom 2
Salt Lake City, UT
DiscGenics is a biotechnology company developing advanced spinal therapeutics to treat patients with diseases of the intervertebral disc. DiscGenics is the only company to utilize therapeutic progenitor cells derived from disc to treat the disc. The Company's allogeneic methodology allows DiscGenics to derive many doses from each adult tissue donation. The Company's first product, Injectable Discogenic Cell Therapy (IDCT), is in preclinical development for the treatment of moderate degenerative disc disease. This cellular treatment offers a cost-effective and non-surgical solution to patients who currently have few treatment options. Further, the treatment may delay the progression towards costly and often ineffective surgical interventions necessary at the late stages of degeneration. A follow-on product utilizing a different scaffold carrier will be for post-discectomy patients and is currently being researched. www.discgenics.com
John Maslowski, Vice President of Scientific Affairs
Oct. 8 | 2:30pm | La Jolla Ballroom 2
Exton, PA
Fibrocell Science is an autologous cell therapy company primarily focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs. Based on its proprietary autologous fibroblast technology, Fibrocell is pursuing breakthrough medical applications of azficel-T for restrictive burn scarring and vocal cord scarring. The company's collaboration with Intrexon Corporation, a leader in synthetic biology, includes using genetically-modified fibroblasts for treating rare and serious skin and connective tissue diseases for which there are currently no approved products. www.fibrocellscience.com
David Green, CEO
Oct. 7 | 2:30pm | La Jolla Ballroom 1
Hilliston, MA
Harvard Apparatus Regenerative Technology (HART) is a clinical-stage biotechnology company making regenerated organs for transplant. The Company's first product, the HART-Trachea, is intended to be used to restore the structure and/or function of a severely damaged trachea. The HART-Trachea is comprised of autologous bone marrow cells seeded on the Company's proprietary InBreath synthetic scaffold in its proprietary InBreath organ bioreactor. To date, HART's InBreath bioreactor technology has been used to treat eight human patients, and the five most recent of these transplants also used HART's InBreath scaffold. The Company believes that its HART-Trachea could enable surgeons to address nearly all life-threatening constrictions of the trachea, and expects to submit its IND application for HART-Trachea to the FDA by the end of 2015. In addition to its trachea product, HART is also working with major medical research institutions to regenerate the lungs, esophagus, lower GI, heart valves and heart. www.harvardapparatusregen.com
Gail Naughton, Ph.D., Chairman & CEO
Oct. 7 | 10:15am | La Jolla Ballroom 2
San Diego, CA
Histogen is a regenerative medicine company manufacturing and developing innovative therapies based on the products of cells grown under simulated embryonic conditions. Through Histogen's proprietary technology process, including conditions of low oxygen and suspension, newborn cells are encouraged to naturally produce vital proteins and growth factors which are characteristic of young, rapidly developing tissue and which can stimulate stem cells in the patient's own body to regenerate into new tissue. Using this patented tissue-engineering platform, Histogen has developed a rich pipeline of unique commercialization opportunities for both aesthetic and therapeutic applications. The Company's lead product, Hair Stimulating Complex (HSC) has shown success in two Company-sponsored clinical trials as an injectable treatment for alopecia. In addition, Histogen's human multipotent cell conditioned media can be found in skincare products including ReGenica, which is distributed by Suneva Medical in partnership with Obagi Medical Products. www.histogen.com
Tom Ulich, M.D., Chief Scientific Officer
Oct. 7 | 3:00pm | La Jolla Ballroom 1
Cambridge, MA
InVivo Therapeutics is a pioneering biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The Company was founded in 2005 with proprietary technology co-invented by Robert Langer, ScD., Professor at Massachusetts Institute of Technology (MIT), and Joseph Vacanti, M.D., who is affiliated with Massachusetts General Hospital. InVivo is developing biocompatible neuro-spinal scaffolds to treat acute SCI and neuro-spinal scaffolds plus stem cells to treat chronic SCI. Data on InVivo's scaffold and scaffold plus stem cells technology was first published in the Proceedings of the National Academy of Sciences (PNAS) in 2002 and has since been demonstrated to successfully promote functional recovery following traumatic spinal cord injury in several models. Data from InVivo's pilot non-human primate study was published in the Journal of Neuroscience Methods in 2010, which earned the David S. Apple Award from the American Spinal Injury Association for its outstanding contribution to spinal cord injury medicine. www.invivotherapeutics.com
Mitchell Seyedin, Ph.D., Executive Chairman
Oct. 7 | 11:15am | La Jolla Ballroom 2
St. Louis, MO
A leading regenerative medicine company focused on developing novel orthobiologic products, the Company has two late-stage development programs targeting areas of significant unmet medical need in spine and sport medicine. The lead product candidates are NuQu for the treatment of discogenic back pain and RevaFlex for articular knee cartilage repair and restoration. ISTO's cartilage regeneration platform uses juvenile cartilage cells that are expanded using a proprietary manufacturing process. Juvenile cartilage cells possess vastly superior regeneration potential compared to adult cartilage cells. In addition to the cartilage regeneration platform, ISTO has developed and markets a synthetic biomaterial for bone generation which is primarily used in spinal fusion applications. InQu is FDA 510(k) cleared for use as a bone graft extender for fusion in all areas of the spine. InQu has been used in over 30,000 procedures and has demonstrated an excellent safety profile. www.istotech.com
Henry Klassen, M.D., Ph.D., Founder
Oct. 7 | 5:30pm | La Jolla Ballroom 2
Newport Beach, CA
jCyte is developing a progenitor cell-based product for use in retinal degenerative diseases, specifically blinding conditions involving the loss of photoreceptors. The initial target disease is the orphan disease known as retinitis pigmentosa (RP) and the follow-on disease target is age-related macular degeneration (AMD). jCyte's novel translational work has received substantial support from the California Institute of Regenerative Medicine (CIRM), first as an Early Translational Grant in the amount of $4 million in 2010 and then in the form of a Disease Team Therapy Development Award for an additional $17.1 million in 2012. This funding provides for IND-enabling preclinical work as well as early-stage clinical trials. jCyte is one of a small number of entities pioneering the application of regenerative medicine-based technologies to unmet medical need in the retina. The immediate goal is to obtain regulatory approval from the FDA for clinical testing in retinitis pigmentosa. www.jcyte.com
Marc Penn, M.D., Ph.D., Founder & Chief Medical Officer
Oct. 8 | 1:45pm | La Jolla Ballroom 2
Cleveland, OH
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. Founded in 2007 with an exclusive license from Cleveland Clinic, Juventas has transitioned its therapeutic platform from concept into Phase II clinical trials for heart failure and critical limb ischemia. The Company's lead product, JVS-100, is a non-viral DNA plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival, recruiting endogenous stem cells to the damaged region and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. www.juventasinc.com
Margo Roberts, Ph.D., Chief Scientific Officer
Oct. 8 | 2:30pm | La Jolla Ballroom 1
Santa Monica, CA
Kite Pharma is developing a pipeline of product candidates for the treatment of advanced solid and hematological malignancies using the Company's therapeutic platform – engineered Autologous Cell Therapy (eACT™) – in which a patient's own T cells, or white blood cells, are engineered to recognize and destroy their cancer. The patient's immune system, particularly T cells, plays a critical role in identifying and killing cancer cells. Kite Pharma's eACT™ technology involves the genetic engineering of T cells to express either chimeric antigen receptors (CARs), or T cell receptors (TCRs). The Company's technology has been developed in part through a collaboration with the National Cancer Institute, Surgery Branch through a cooperative research and development agreement (CRADA). Kite Pharma is advancing a pipeline of proprietary eACT™-based product candidates to create personalized therapies targeting a broad range of indications in cancer. www.kitepharma.com
Doug Doerfler, President & CEO
Oct. 8 | 1:30pm | La Jolla Ballroom 2
Gaithersburg, MD
MaxCyte specializes in cell modification technologies to enable the discovery, development, manufacturing and delivery of innovative cell-based therapeutic products. MaxCyte is pioneering the use of mRNA for Chimeric Antigen Receptor (CAR) immunotherapies for solid cancers with Drs. Carl June and Dario Campagna. Early in 2013, MaxCyte received U.S. patent 8,450,112 providing broad coverage for transiently modifying unexpanded cells (specifically, unstimulated resting PBMCs) to express CARs for treating cancer. This approach, building on the work with Dr. June and others and pioneered by MaxCyte, enables the dramatic reduction of costs and processing times (from two weeks to less than one day), leveraging existing leukopheresis infrastructure to create a rapid, truly commercializable and cost-effective form in mRNA CAR cancer therapies. www.maxcyte.com
Antonio Lee, Ph.D., CEO & Managing Director
Oct. 7 | 10:45am | La Jolla Ballroom 2
Rockville, MD
MEDIPOST is a leading stem cell biotechnology company focused on developing stem cell therapeutics using human Umbilical Cord Blood-derived Mesenchymal Stem Cells (hUCB-MSCs) to meet unmet medical needs such as those related to regenerative or functional recovery of knee articular cartilage, the nervous system, the pulmonary system and hematopoietic transplantation engraftment areas. CARTISTEM® is the world's first allogeneic stem cell product with a Biologics License Application (BLA) approved by the Ministry of Food and Drug Safety (MFDS) Korea (former KFDA) for the regeneration of knee cartilage for the sufferers of degenerative osteoarthritis. CARTISTEM® contains multi-potent human Umbilical Cord Blood-derived Mesenchymal Stem Cells (hUCB-MSCs) with unique characteristics including not provoking an immune-response when transplanted into unrelated recipients. This allows large-scale manufacturing of CARTISTEM® using freshly isolated MSCs from the voluntarily donated cord blood units. www.medipostamerica.com
Donna Skerrett, M.D., Chief Medical Officer
Oct. 7 | 10:30am | La Jolla Ballroom 1
Melbourne, Australia
Mesoblast Limited is developing novel biotherapeutics derived from its proprietary adult stem cell-based technologies. The Company's technology platforms have the potential to deliver a diverse portfolio of clinical-stage products to treat a broad range of conditions with major unmet medical needs. Its strategic product development focus is in four major and distinct areas – systemic inflammatory conditions, cardiovascular diseases, orthopedic diseases of the spine and oncology conditions. Mesoblast's corporate strategy is to: leverage proprietary cell-based and complementary biologic technologies to develop products for unmet medical needs; bring multiple products to market within a parallel timeframe; underpin future financial growth through investing in manufacturing operations; and enhance the likelihood of commercial success through strategic partnerships. Mesoblast's strong cash reserves ($242 million at 31 March 2014) enable simultaneous product development with future revenues expected from milestone payments, distribution arrangements and direct sales. www.mesoblast.com
Thomas Koob, Ph.D., Chief Scientific Officer
Oct. 7 | 5:00pm | La Jolla Ballroom 1
Marietta, GA
MiMedx®, the premier processor of regenerative biomaterial products and implants from human amniotic membrane, has distributed hundreds of thousands of amniotic tissue grafts worldwide. Profound clinical outcomes have been achieved in therapeutic areas including ophthalmology, spine, wounds, dental, orthopaedic, surgery, sports medicine and urology. With this innovative allograft that promotes bioactive healing, MiMedx® believes its intellectual property and proprietary processing technique strategically positions the Company as the leader in this area of regenerative medicine. www.mimedx.com
Robin Smith, M.D., Chairman & CEO
Oct. 7 | 11:15am | La Jolla Ballroom 1
New York, NY
NeoStem is a leader in the emerging cellular therapy industry, pursuing the preservation and enhancement of human health globally through the development of cell-based therapeutics that prevent, treat or cure disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function. The business includes the development of novel proprietary cell therapy products as well as a revenue-generating contract development and manufacturing service business. This combination has created an organization with unique capabilities for cost effective in-house product development and immediate revenue and cash flow generation. www.neostem.com
Sharon Presnell, Ph.D., Chief Technology Officer
Oct. 7 | 2:45pm | La Jolla Ballroom 1
San Diego, CA
Organovo designs functional human tissues. The Company's bioprinting technology enables the creation of 3D tissues that more accurately reproduce native tissues. Organovo's focus is on developing a range of tissue and disease models for medical research and therapeutic applications. www.organovo.com
Lode Debrabandere, Ph.D., CEO
Oct. 7 | 5:15pm | La Jolla Ballroom 1
Columbia, MD
Through over 20 years of research, experience and understanding, Osiris Therapeutics has led the way in mesenchymal stem cell (MSC) science and the clinical application of cellular therapies. From commercializing its first generation implantable product, Osteocel, to achieving the Company's initial goal, when founded in 1992, of developing the world's first approved stem cell drug, remestemcel-L for graft versus host disease, Osiris has written the book on regenerative medicine. Today, as the leading stem cell company, Osiris continues to address unmet medical needs with innovative approaches in developing and marketing products in wound care, orthopedics and sports medicine. Never forgetting that the Company's products are differentiated by scientific excellence, Osiris' current product line includes Grafix® for acute and chronic wounds, Cartiform®, a viable cartilage mesh for cartilage repair, and OvationOS®, a viable bone matrix used for bone repair and regeneration. www.osiris.com
Kyriacos Mitrophanous, Ph.D., Head of Research
Oct. 8 | 1:45pm | La Jolla Ballroom 1
Oxford, United Kingdom
Oxford BioMedica is a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs. The Company's technology platform includes a highly efficient gene delivery system (LentiVector®), which has specific advantages for targeting diseases of the central nervous system and the eye, and a unique tumor antigen (5T4), which is an ideal target for anti-cancer therapy. www.oxfordbiomedica.co.uk
Eric Halioua, CEO
Oct. 7 | 5:00pm | La Jolla Ballroom 2
Mont-Saint-Guibert, Belgium
Promethera Biosciences is a pharmaceutical company that develops innovative cell therapies for the treatment of liver disease. Promethera® HepaStem is a cell therapy product based on the use of allogeneic stem cells isolated from healthy adult human livers, Heterologous Human Adult Liver Progenitor Cells (HHALPC). These cells can be used to treat a wide variety of liver diseases, from rare inborn metabolic diseases (which can be classified as orphan diseases and mainly affect children), to acquired deficiencies affecting adults, such as liver fibrosis. This treatment has already received the orphan drug designation from the European Medicines Agency and the FDA for the treatment of two very debilitating pediatric pathologies. Promethera Biosciences is conducting a prospective, open label, multicenter, partially randomized Phase I/II study testing one cycle of Promethera® HepaStem designed to evaluate the safety and preliminary efficacy in Urea Cycle Disorders and Crigler-Najjar Syndrome patients. www.promethera.com
John Martin, Executive Chairman
Oct. 7 | 3:00pm | La Jolla Ballroom 2
Gordon, Australia
Regeneus is a Sydney-based regenerative medicine company founded in August 2007 that is focused on using the regenerative capacities of adipose-derived cells to develop innovative cell therapies for humans and animals. Regenerative medicine is a rapidly growing multidisciplinary specialty that is focused on the repair or regeneration of cells, tissues and organs. The primary goal is to enhance the body's natural ability to replace tissue damaged or destroyed by injury or disease. www.regeneus.com.au
Michael Hunt, CEO
Oct. 7 | 2:15pm | La Jolla Ballroom 1
Guildford, England
ReNeuron is a leading clinical-stage cell therapy development business. Based in the U.K., its primary objective is the development of novel cell-based therapies targeting areas of significant unmet or poorly met medical need. ReNeuron has used its unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered "off-the-shelf" to any eligible patient without the need for additional immunosuppressive drug treatments. The Company's therapeutic candidates for stroke disability and critical limb ischemia are in clinical development and its cell-based treatment for blindness-causing diseases of the retina is currently in pre-clinical development. ReNeuron is also advancing a proprietary platform technology to exploit nanoparticles (exosomes) secreted by stem cells as potential new drug candidates targeting indications in tissue repair, fibrosis and cancer. www.reneuron.com
David Hall, CEO
Oct. 7 | 11:45am | La Jolla Ballroom 2
Vancouver, BC
RepliCel is a regenerative medicine company focused on autologous cell therapies that address diseases caused by a deficit of healthy cells required for healing and function such as chronic tendinosis, damaged skin and pattern baldness. The Company's RCT-01 and RCS-01 therapies treat chronic tendinosis and damaged skin using fibroblasts isolated from the sheath of the hair follicle. RCH-01 is another hair follicle derived cell therapy for the treatment of pattern baldness. In all indications, specific cells are isolated, replicated into the millions and delivered back into the patient to reactivate a stalled healing process. These products utilize the Company's proprietary manufacturing and cell expansion platform. RepliCel is also developing cell injector devices for dermal injections. In addition to addressing the delivery requirements for RCH-01 and RCS-01, they should have applications in many current dermatological injection procedures. www.replicel.com
Teresa Leezer, CEO
Oct. 8 | 4:15pm | La Jolla Ballroom 2
Louisville, KY
RhinoCyte, Inc. is a privately owned biopharmaceutical company focused on developing transformational technologies that will change the way neurodegenerative disorders are treated. Founded in 2005, the Company is advancing innovative treatment paradigms that leverage proprietary cell therapies for high unmet clinical needs including Spinal Cord Injury (SCI), Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS) Multiple Sclerosis (MS) and Type 1 Diabetes. RhinoCyte leverages novel regenerative therapies to extend and enhance the quality of human life without immunosuppression or genetic manipulation. www.rhinocyte.com
Curt Herberts, Senior Director, Corporate Development & Strategy
Oct. 8 | 1:15pm | La Jolla Ballroom 1
Richmond, CA
Sangamo is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies for unmet medical needs. The Company is a worldwide leader in the development of a proprietary technology platform that enables specific regulation of gene expression and gene modification. The basis of this platform is a naturally occurring class of transcription factors, zinc finger DNA-binding proteins (ZFPs) which can be engineered to drive desired therapeutic outcomes. Engineered ZFPs can be linked to functional domains to create ZFP transcription factors (ZFP TFs) capable of turning genes on or off. The Company can also link ZFPs to nuclease domains to create zinc finger nucleases (ZFNs) which enable precise gene-editing in cells. Engineered ZFNs can modify a cell's DNA at a precise location, thereby facilitating correction or disruption of a specific gene or the targeted addition of a new DNA sequence. www.sangamo.com
Jill Helms, Ph.D., Professor of Surgery
Oct. 7 | 10:30am | La Jolla Ballroom 2
Stanford, CA
(Academic Institution)
At Stanford, the goal is to discover new ways to remain fit and vigorous, well into old age. The university has identified and characterized a potent stem cell activator, WNT and shown that it activates both embryonic and adult stem cells in a wide range of assays. With CIRM funding, the university has developed a strategy for activating a patient's own bone stem cells to reinvigorate the body's natural regenerative process. The end result is rapid healing, back to the levels appreciated in youth.
Martin McGlynn, President & CEO
Oct. 7 | 3:15pm | La Jolla Ballroom 1
Newark, CA
StemCells, Inc. is engaged in research and clinical development of cell-based therapeutics using the Company's platform technology, a proprietary highly purified population of human neural stem cells, HuCNS-SC® cells. The Company is developing therapies for central nervous system disorders. The Company completed enrollment in a Phase I/II clinical trial in spinal cord injury and has reported positive data for the first eight patients. The Company is also conducting a Phase I/II clinical trial in dry age-related macular degeneration (AMD). Both studies release final results next year. StemCells, Inc. is pursuing preclinical studies in Alzheimer's disease with funding support from the California Institute of Regenerative Medicine (CIRM). In a Phase I clinical trial in Pelizaeus-Merzbacher disease (PMD), a fatal childhood myelination disorder, the Company showed preliminary evidence of donor-derived myelination in all four patients. StemCells, Inc. also markets stem cell research products including media and reagents under the SC Proven® brand. www.stemcellsinc.com
Michael Leek, Ph.D., CEO
Oct. 7 | 2:45pm | La Jolla Ballroom 2
Edinburgh, Scotland
Commercializing the anti-cancer cytotoxicity exhibited by γδ T cells, TC BioPharm is developing an autologous therapy which involves expansion of the cells over a two-three week period to formulate a treatment for a wide-variety of different tumor types. The manufacturing process comprises several steps. The first involves isolation of peripheral blood mononuclear cells; the second involves selection/activation of γδ T cells; the final stage requires culture expansion in a GMP environment, providing therapeutically relevant cell numbers prior to administration. Although there are many different approaches to T cell immunotherapy, the process has a compelling clinical safety and efficacy record, demonstrated by a cohort of published case histories. Moreover, when contrasted with novel immunotherapies such as PDL-1 and CTLA-4 inhibitors being developed by Roche and Bristol Myers Squibb respectively, use of γδ T cells may have a complimentary and synergistic therapeutic benefit. www.tcbiopharm.com
Sven Lee, Global Director, Sales & Business Development, Cell Processing
Oct. 8 | 2:00pm | La Jolla Ballroom 2
Lakewood, CO
(4543: Tokyo)
Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction coupled with leading technologies in therapeutic apheresis and cell processing. Terumo believes in the potential of blood to do even more for patients than it does today. This belief inspires the Company's innovation and strengthens Terumo's collaboration with customers. Terumo BCT -Unlocking the Potential of Blood. www.terumobct.com
Eduardo Bravo, CEO
Oct. 7 | 5:30pm | La Jolla Ballroom 1
Leuven, Belgium
(NYSE Euronext: TIG)
TiGenix was founded in 2000 to clinically develop and bring to market novel cell therapeutic products. In 2009, the Company became the first European company to obtain centralized marketing authorization for an Advanced Therapeutic Medicinal Product (ATMP) with its Chondrocelect product, which is currently on the market in various countries in Europe. The Company's merger with Cellerix in 2011 secured long-term growth through a clinical-stage pipeline of allogeneic adult Mesenchymal Stem Cells (MSCs). The most advanced product of this pipeline is poised to deliver Phase III results in 2015. The Company has been listed on NYSE Euronext Brussels since March 2007. Roughly 70% of the outstanding shares represent free-float, with the remaining shares being in the hands of stable reference shareholders. www.tigenix.com
Donald Kohn, M.D., Professor
Oct. 7 | 3:15pm | La Jolla Ballroom 2
Los Angeles, CA
(Academic Institution)
Sickle cell disease may be treated with allogeneic hematopoietic stem cell transplantation (HSCT), but is limited by the need to find a suitable matching donor and immunological risks. Stem cell gene therapy can allow an autologous HSCT to be done using the patient's own bone marrow stem cells without the immune complications. We have developed a lentiviral vector that adds to hematopoietic stem cells a modified version of human beta-globin that prevents sickling of red blood cells. A Phase I clinical trial funded by CIRM Disease team Awards (DR1-01452 and DR3-06945) will be initiated in 2014 to assess feasibility, safety and secondary end-points of efficacy. Stem cell gene therapy may provide a safe and improved therapy for sickle cell disease.
Paul Laikind, Ph.D., President & CEO
Oct. 7 | 2:15pm | La Jolla Ballroom 2
San Diego, CA
ViaCyte, a private company in the field of regenerative medicine, is currently focused on developing a novel cell therapy for the treatment of diabetes. The Company's lead product candidate, VC-01, is based on the production of pancreatic progenitors derived from human pluripotent stem cells. These cells are implanted in a durable and retrievable encapsulation device called the Encaptra® drug delivery system. Once implanted and matured, these cells are designed to secrete insulin and other regulatory factors in response to blood glucose levels. ViaCyte is headquartered in San Diego, California with additional operations in Athens, Georgia. The Company is funded in part by the California Institute for Regenerative Medicine (CIRM) and the Juvenile Diabetes Research Foundation (JDRF). www.viacyte.com
Jeff Goater, VP, Business Development
Oct. 8 | 1:15pm | La Jolla Ballroom 2
Cambridge, MA
Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system. The Company's founders include scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference and neuroscience. Voyager's management team has deep expertise and a track record of building exceptional life science companies. The Company has developed a product engine that may transform treatment for a wide range of diseases. Voyager's pipeline includes VY-AADC01 for Parkinson's disease, VY-SOD101 for a monogenic form of ALS and VY-FXN01 for Friedreich's ataxia. Voyager is committed to advancing the field of AAV gene therapy by innovating and investing in areas such as vector optimization and engineering, dosing techniques, as well as process development and production. Voyager is a private company launched in February 2014 with $45 million in Series A venture capital financing from Third Rock Ventures. www.voyagertherapeutics.com


text:
Amerie is out with the video to her new single 'Why R U?', the first release from the American R&B singer's fourth studio album 'In Love & War', out August 11th on Def Jam. Watch the Ray Kay directed video below the cut.
Recent Posts:
- Usher 'Good Kisser' Video
- Rihanna Joins Melyssa Ford At Roxbury
- Christina Milian Calls Jas Prince Her "Fiance" At 32nd Birthday Party
- John Legend Talks About His New Album 'Love In The Future'
- Chris Brown: I Can't Focus On Wife-ing Rihanna
- Ne-Yo Talks 'R.E.D.' And A&R Role At Motown
- Trevor Jackson Shoots Music Video With Zendaya Coleman
- Solange Knowles 'Losing You' Video


text:
Yamaha TT-R90 MX Motorcycle: When it's time to step it up a notch, the three-speed automatic-clutch four-stroke-powered TT-R90E is the way to go. Complete with big TT-R styling cues and electric start.
Range of prices within this search:
Your browser does not support iframes.
Copyright © 2014 Dominion Enterprises. All Rights Reserved


text:
The search for a missing teenage girl, who was last seen almost two weeks ago, continuesy.
Officers searched further areas in Pill, Newport, yesterday in the hunt for 18-year-old Nida Ul-Naseer, who was last seen on December 28 when she took the rubbish out of her Newport home on Linton Street.
Police have already searched the areas around the Transporter Bridge, Lysaght Institute and Pill Millennium Centre.
South Wales East Assembly Member Mohammad Asghar said the family have been in "very close" contact with the police and that he has been invited to a police briefing with Nida's family on Monday.
Mr Asghar said he is "very confident" in the police's operation and said they are devoting a lot of resources to it.
He said they are doing a "wonderful job" especially in the recent poor weather conditions.
The AM said: "I am very much impressed, especially in the circumstances and they're still on it, they haven't closed the file. I am sure they will find Nida. We hope for good news soon."
Mr Asghar, whose constituency office is in Newport, said he has visited the family at their home and said a friend of his is also a friend of Nida's family.
Mr Asghar said they are "totally devastated".
He said: "They are losing sleep and appetite. Being a father of a daughter myself I can imagine what it must be like. They are a very close-knit family and are supportive and helpful to each other."
He added: "The community is very concerned about her. Most of them feel like she's their own family member.
"No matter where she is, we just want her to come home safely."
At a press conference on Tuesday, Nida's family pleaded for her to come home.
The 18-year-old's sister said Nida had been upset because her family's asylum-seeker status barred her from attending university.
Shamyla Naseer, 23, said: "Nida, please come back home. Nida, please come back home. We are desperately worried about you. Nida, we need you. Nida, please come back home, we cannot live without you."
Nida's father, Dr Naseer Tahir, said he felt his daughter blamed him as "head of the family" for her inability to go to university.
Speaking direct to Nida, he added: "We miss you, we love you, we worry about your future."
Nida is of Asian-Pakistani appearance and has long dark hair, is slim and is 5ft 3in tall.
She was last known to be wearing blue jeans and a black top.
Anyone with information is urged to call Gwent Police on 101 quoting log number 448 28/12/13


text:
american airlines
03/14/2014 - 14:00
American Airlines Group's system cargo tonne miles (CTMs) for February were 173.5 million, up 11.2 percent versus February 2013. Year-to-date CTMs for American Airlines Cargo and... Read more
03/12/2014 - 14:35
Cargo plays a major role in American Airlines' operations, generating more than $800 million in cargo revenue annually, COO Robert Isom said during the Opening Plenary session at... Read more
02/12/2014 - 16:16
American Airlines Cargo set a new system-wide record in January for the total amount of cargo carried on one of its new B777-300ER aircraft. American's ground handling team in Los... Read more
01/16/2014 - 14:34
American Airlines Group reported positive year-over-year traffic growth in 2013 for both American Airlines Cargo and US Airways Cargo. American's cargo volumes in December 2013... Read more
12/13/2013 - 03:00
American Airlines' November cargo volumes were up nearly 17 percent year over year, AMR Corporation reported. "We're very pleased with the legacy American achieving its seventh... Read more
12/09/2013 - 10:10
AMR Corporation and US Airways Group, Inc. announced Monday the completion of their merger to officially form American Airlines Group Inc. and begin building the new American... Read more
12/03/2013 - 03:00
American Airlines Cargo has been expanding service throughout the Americas during 2013. In its latest addition, AA began offering full cargo service to and from Minneapolis/St.... Read more
10/08/2013 - 03:00
American Airlines Cargo began offering full cargo service to and from Orlando, Fla., effective Oct. 7. American offers regular connections between Orlando and its five hubs:... Read more
09/27/2013 - 09:44
American Airlines Cargo delivered more than 200 pieces of gold and ancient artifacts to London. The artifacts are for one of the British Museum's upcoming fall exhibitions,... Read more
09/11/2013 - 07:00
American Airlines Cargo signed the International Air Transport Association Multilateral e-AWB Agreement, moving the airline one step closer to paperless airfreight operations. "... Read more